Anti-inflammatory effects of novel sinomenine derivatives

International Immunopharmacology

Volumn 29, Issue 2, 2015, Pages 354-360

  Zhao, Zijian ^a,b   Xiao, Jing ^a   Wang, Jiancheng ^a   Dong, Wanrong ^a   Peng, Zhihong ^a   An, Delie ^a  

^a HUNAN UNIVERSITY   (China)

^b HUAIHUA UNIVERSITY   (China)

Author keywords

Anti inflammation; Derivatives; IL 1 ; IL 6; Sinomenine; TNF

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SINOMENINE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CARRAGEENAN; COLORING AGENT; EVANS BLUE; IL1B PROTEIN, MOUSE; INTERLEUKIN-6, MOUSE; LIPOPOLYSACCHARIDE; MORPHINAN DERIVATIVE; TUMOR NECROSIS FACTOR; XYLENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; CARRAGEENAN-INDUCED PAW EDEMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; EAR EDEMA; HALF LIFE TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; EDEMA; FOOT; GENETICS; MOUSE; PATHOLOGY; SINOMENIUM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAPILLARY PERMEABILITY; CARRAGEENAN; COLORING AGENTS; EDEMA; EVANS BLUE; FOOT; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MORPHINANS; RATS; RATS, SPRAGUE-DAWLEY; SINOMENIUM; TUMOR NECROSIS FACTOR-ALPHA; XYLENES;

EID: 84948472375     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.10.030     Document Type: Article

References (32)

1. Z.S. Huang, and N. Wang Clinical observation on treatment of rheumatoid arthritis with zhengqing fengtongning retard tablets Hebei Med. J. 32 2010 59 60
2. M. Xu, L. Liu, C. Qi, B. Deng, and et al. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis Planta Med. 74 2008 1423 1429
3. S.X. Fu, S.S. Chang, Y.S. Li, and N.C. Wang The toxicity and general pharmacological actions of sinomenine Acta Pharm. Sin. 10 1963 673 676
4. L. Liu, E. Buchner, D. Beitze, C.B. Schmidt-Weber, and et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine Int. J. Immunopharmacol. 18 1996 529 543
5. L. Luo, G.J. Yan, J.C. Song, and S.D. Luo Anti-inflammatory and analgesic effects of benzoyl sinomenine Chin. J. Hosp. Pharm. 3 2005 196 198
6. J. Yang, L. Luo, W. Zhao, and S.D. Luo Synthesis of sinomenine's derivatives and their analgesic and anti-inflammatory quantitative structure-activity relationships Med. J. Wuhan Univ. 30 2009 29 32
7. Y. Wang, and L.L. Zhou Study on the preparation and stability of sinomenine liposomes Chin. Tradit. Patent Med. 7 2005 757 760
8. Y. Wang, Y.F. Fang, W.H. Huang, X. Zhou, and et al. Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats J. Ethnopharmacol. 98 2005 37 40
9. A.L. Wang, Z.B. Li, M. Yuan, A.C. Yu, and et al. Sinomenine inhibits activation of rat retinal microglia induced by advanced glycation end products Int. Immunopharmacol. 7 2007 1552 1558
10. J.H. Liu, W.D. Li, H.L. Teng, and Z.B. Lin Immunopharmacological action of sinomenine, an alkaloid isolated from Sinomenium acutum, and its mechanism of action in treating rheumatoid arthritis Acta Pharm. Sin. 40 2005 127 131
11. Y. Cheng, J.B. Zhang, W.P. Hou, D.H. Wang, and et al. Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis Int. Immunopharmacol. 9 2009 894 899
12. L. Qian, Z.L. Xu, W. Zhang, B. Wilson, and et al. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase J. Neuroinflammation 4 2007 23
13. Y.T. Lou, H.B. Zhou, J. Zou, L.C. Yan, and et al. Modification of poorly bioactive sinomenine into more potent immunosuppressive agents by embedding of drug-like fragments Tetrahedron Lett. 51 2010 485 488
14. Y. Wang, B. Zhong, Y.F. Fang, J.Y. Li, and et al. Effects of sinomenine on inflammatory cytokines and anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis Acta Acad. Med. Militaris Tertiae 27 2005 1573 1575
15. W. Liu, X.Y. Liu, and B. Liu Clinical observation on treatment of rheumatoid arthritis with zhengqing fengtongning retard tablets: a report of 60 cases J. Chin. Integr. Med. 4 2006 201 202
16. X.J. Lin, X.Y. Cai, and J.H. Ye The clinical observation on sinomenine for rheumatoid arthritis J. Tradit. Chin. Med. Univ. Hunan 29 2009 52 54
17. G.D. Huang, J.B. Li, Y.H. Huang, D.F. Huang, and et al. The clinical study on sinomenine for 100 patients with rheumatoid arthritis J. Emerg. Tradit. Chin. Med. 16 2007 416 417
18. M.R. Ye, L. Liu, Y.E. Zeng, L.Q. Zhang, and et al. Studies on the relationship between sinomenine distribution and its organic toxicology Chin. Pharmacol. Bull. 17 2001 65 69
19. J. Wu, and Y.-H. Li The side effects and prevention of drug treatment by zhengqing fengtongning Chin. J. Med. Guide 14 2012 250 251
20. L.G. He, X.L. Li, X.Z. Zeng, H. Duan, and et al. Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation Acta Pharmacol. Sin. 35 2014 203 210
21. Y. Sun, Y. Yao, and C.Z. Ding A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines Int. Immunopharmacol. 18 2014 135 141
22. X.F. Niu, H. Yao, W.F. Li, Q. Mu, and et al. δ-Amyrone, a specific inhibitor of cyclooxygenase-2, exhibits anti-inflammatory effects in vitro and in vivo of mice Int. Immunopharmacol. 21 2014 112 118
23. G.F. Dai, J. Zhao, Z.W. Jiang, L.P. Zhu, and et al. Anti-inflammatory effect of novel andrographolide derivatives through inhibition of NO and PGE2 production Int. Immunopharmacol. 11 2011 2144 2149
24. T.L. Gao, J.X. Hao, Z. Wiesenfeld-Hallin, D.Q. Wang, and et al. Analgesic effect of sinomenine in rodents after inflammation and nerve injury Eur. J. Pharmacol. 721 2013 5 11
25. Y.H. Tan, S.J. Deng, G.Y. Huang, Y. Wang, and et al. Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats J. Ethnopharmacol. 98 2005 37 43
26. Z.S. Deng, J.X. Li, P. Teng, P. Li, and et al. Biocatalyzed cross-coupling of sinomenine and guaiacol by Antrodiella semisupina Org. Lett. 10 2008 1119 1122
27. Y. Zhao, J. Li, K.Q. Yu, Y. Liu, and et al. Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa β Int. Immunopharmacol. 7 2007 637 645
28. Y.L. Chen, L.L. Zhang, X.L. Lu, K. Wu, and et al. Sinomenine reverses multidrug resistance in bladder cancer cells via P-glycoprotein-dependent and independent manners Pharmazie 69 2014 48 54
29. F. Liao, Z.R. Yang, X.H. Lu, X. Guo, and et al. Sinomenine sensitizes gastric cancer cells to 5-fluorouracil in vitro and in vivo Oncol. Lett. 6 2013 1604 1610
30. J.P. Wang, J.L. Ruan, C.G. Zhang, Y. Ye, and et al. Development and evaluation of the sinomenine transdermal patch Pak. J. Pharm. Sci. 4 2008 407 410
31. Q. Liu, L.L. Zhou, and R. Li Study on releasing rate of sinomenine TDD Chin. Tradit. Patent Med. 21 1999 279 281
32. L.C. Yan, E.G. Bi, Y.T. Lou, X.D. Wu, and et al. Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis Biochem. Biophys. Res. Commun. 391 2010 1093 1098